We investigated the baseline metabolic activity of SHMT2 and the effect of SHMT2 inhibition in thyroid cancer cells using SHIN2, an SHMT inhibitor that was previously developed as a small molecule to attenuate tumor growth in leukemia41. Here, SHMT2 is linked to thyroid gland carcinoma.